Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 23500658)

1.

Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice.

Zheng N, Lin X, Wen Q, Kintoko, Zhang S, Huang J, Xu X, Huang R.

Toxicol Lett. 2013 May 10;219(1):77-84. doi: 10.1016/j.toxlet.2013.03.001. Epub 2013 Mar 13.

PMID:
23500658
3.

The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.

Liu IM, Tzeng TF, Liou SS, Chang CJ.

J Ethnopharmacol. 2009 Jul 15;124(2):211-8. doi: 10.1016/j.jep.2009.04.021. Epub 2009 May 3.

PMID:
19397971
4.

Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.

Liu IM, Tzeng TF, Liou SS, Chang CJ.

J Food Sci. 2011 Sep;76(7):H165-74. doi: 10.1111/j.1750-3841.2011.02310.x. Epub 2011 Aug 22.

PMID:
22417553
5.

A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.

Yokozawa T, Yamabe N, Cho EJ, Nakagawa T, Oowada S.

Nephron Exp Nephrol. 2004;97(2):e38-48.

PMID:
15218322
6.

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G.

Kidney Int. 1996 Aug;50(2):627-34.

PMID:
8840295
7.

Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?

McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE.

Kidney Int. 2007 Aug;72(4):481-8. Epub 2007 Jun 6.

PMID:
17554258
8.

Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.

Okamoto T, Park CH, Noh JS, Toriizuka K, Sei Y, Park JC, Yokozawa T.

J Pharm Pharmacol. 2011 Jul;63(7):952-9. doi: 10.1111/j.2042-7158.2011.01299.x.

PMID:
21635261
9.

Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S.

Br J Pharmacol. 2008 Jul;154(5):1025-34. doi: 10.1038/bjp.2008.155. Epub 2008 Apr 21.

10.

The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.

Lee SH, Kim YS, Lee SJ, Lee BC.

J Ethnopharmacol. 2011 Oct 11;137(3):1409-14. doi: 10.1016/j.jep.2011.08.007. Epub 2011 Aug 11.

PMID:
21856399
11.

Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.

Sohn EJ, Kim CS, Kim YS, Jung DH, Jang DS, Lee YM, Kim JS.

Life Sci. 2007 Jan 9;80(5):468-75. Epub 2006 Oct 6.

PMID:
17070554
12.

Protective effects of total extracts of Averrhoa carambola L. (Oxalidaceae) roots on streptozotocin-induced diabetic mice.

Xu X, Liang T, Wen Q, Lin X, Tang J, Zuo Q, Tao L, Xuan F, Huang R.

Cell Physiol Biochem. 2014;33(5):1272-82. doi: 10.1159/000358695. Epub 2014 Apr 28.

PMID:
24802264
13.

Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.

Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ.

J Ethnopharmacol. 2011 Dec 8;138(3):731-6. doi: 10.1016/j.jep.2011.10.015. Epub 2011 Oct 19.

PMID:
22027446
14.

Novel inhibitors of glycation and AGE formation.

Rahbar S.

Cell Biochem Biophys. 2007;48(2-3):147-57.

PMID:
17709884
15.

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

J Am Soc Nephrol. 2004 Aug;15(8):2125-38.

16.

Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.

Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME.

J Am Soc Nephrol. 2001 Oct;12(10):2098-107.

17.

Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.

Ohtomo S, Nangaku M, Izuhara Y, Takizawa S, Strihou Cv, Miyata T.

Nephrol Dial Transplant. 2008 Apr;23(4):1166-72. Epub 2007 Oct 28.

18.

Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.

Liu K, Xu H, Lv G, Liu B, Lee MK, Lu C, Lv X, Wu Y.

Life Sci. 2015 Feb 15;123:78-85. doi: 10.1016/j.lfs.2014.12.028. Epub 2015 Jan 23.

PMID:
25623853
19.

Hypoxia in the diabetic kidney is independent of advanced glycation end-products.

Nordquist L, Liss P, Fasching A, Hansell P, Palm F.

Adv Exp Med Biol. 2013;765:185-93. doi: 10.1007/978-1-4614-4989-8_26.

PMID:
22879032
20.

Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.

Hirasawa Y, Sakai T, Ito M, Yoshimura H, Feng Y, Nagamatsu T.

Eur J Pharmacol. 2011 Dec 15;672(1-3):159-68. doi: 10.1016/j.ejphar.2011.09.185. Epub 2011 Oct 2.

PMID:
21989075
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk